Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Therapeuticsmd Inc (TXMD)

Therapeuticsmd Inc (TXMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 24,332
  • Shares Outstanding, K 11,532
  • Annual Sales, $ 1,300 K
  • Annual Income, $ -10,280 K
  • 60-Month Beta 1.07
  • Price/Sales 18.95
  • Price/Cash Flow N/A
  • Price/Book 0.86
Trade TXMD with:

Options Overview Details

View History
  • Implied Volatility 317.78% ( +8.86%)
  • Historical Volatility 32.48%
  • IV Percentile 93%
  • IV Rank 39.11%
  • IV High 803.91% on 03/18/24
  • IV Low 5.57% on 10/12/23
  • Put/Call Vol Ratio 0.00
  • Today's Volume 10
  • Volume Avg (30-Day) 10
  • Put/Call OI Ratio 0.52
  • Today's Open Interest 400
  • Open Int (30-Day) 400

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.84 +16.30%
on 05/03/24
2.25 -4.89%
on 05/17/24
+0.22 (+11.46%)
since 04/24/24
3-Month
1.84 +16.30%
on 05/03/24
2.75 -22.18%
on 03/06/24
-0.11 (-4.89%)
since 02/23/24
52-Week
1.84 +16.30%
on 05/03/24
4.50 -52.44%
on 06/06/23
-2.19 (-50.58%)
since 05/24/23

Most Recent Stories

More News
TherapeuticsMD: Q1 Earnings Snapshot

TherapeuticsMD: Q1 Earnings Snapshot

TXMD : 2.14 (+1.42%)
TherapeuticsMD: Q3 Earnings Snapshot

TherapeuticsMD: Q3 Earnings Snapshot

TXMD : 2.14 (+1.42%)
TherapeuticsMD: Q2 Earnings Snapshot

TherapeuticsMD: Q2 Earnings Snapshot

TXMD : 2.14 (+1.42%)
TherapeuticsMD: Q1 Earnings Snapshot

TherapeuticsMD: Q1 Earnings Snapshot

TXMD : 2.14 (+1.42%)
All You Need to Know About TherapeuticsMD (TXMD) Rating Upgrade to Buy

TherapeuticsMD (TXMD) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

TXMD : 2.14 (+1.42%)
TherapeuticsMD Announces Full Year 2022 Financial Results and Provides Update on Business Model Transition

TherapeuticsMD, Inc. (“TherapeuticsMD” or the “Company”) (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results for the full year ended December...

TXMD : 2.14 (+1.42%)
TherapeuticsMD Completes Transaction to License Its Products to Mayne Pharma

TherapeuticsMD, Inc. (NASDAQ: TXMD) (“TherapeuticsMD,” “TXMD” or the “Company”), an innovative, leading women’s healthcare company, today announced that it has completed its previously announced...

TXMD : 2.14 (+1.42%)
Pre-Market Brief: Stocks Mixed As Labor Market Strength Weigh On Sentiment

December S&P 500 futures (ESZ22) are trending down -0.30% this morning after three major US benchmark indices closed mixed on Friday as the November payrolls report fueled expectations the Federal Reserve...

ESZ22 : 3,871.47s (-0.66%)
TXMD : 2.14 (+1.42%)
IOVA : 10.01 (-2.44%)
IMPP : 4.28 (+4.14%)
CLVS : 0.0812 (-5.58%)
UTHR : 272.88 (-1.31%)
SBUX : 78.87 (+0.72%)
TherapeuticsMD Announces Definitive Agreements to License its Products to Mayne Pharma

TherapeuticsMD, Inc. (NASDAQ: TXMD) (“TherapeuticsMD,” “TXMD” or the “Company”), an innovative, leading women’s healthcare company, today announced that it has entered into definitive agreements...

TXMD : 2.14 (+1.42%)
TherapeuticsMD (TXMD) Reports Q3 Loss, Lags Revenue Estimates

TherapeuticsMD (TXMD) delivered earnings and revenue surprises of -53.43% and 30.74%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

TXMD : 2.14 (+1.42%)
IDXG : 1.4800 (+7.25%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

TherapeuticsMD, Inc. is a specialty pharmaceutical company focused on creating branded prescription, generic prescription and over-the-counter products targeted exclusively for women. It is developing three advanced hormone replacement products designed to alleviate the symptoms of and reduce the health...

See More

Key Turning Points

3rd Resistance Point 2.22
2nd Resistance Point 2.18
1st Resistance Point 2.16
Last Price 2.14
1st Support Level 2.10
2nd Support Level 2.06
3rd Support Level 2.04

See More

52-Week High 4.50
Fibonacci 61.8% 3.48
Fibonacci 50% 3.17
Fibonacci 38.2% 2.86
Last Price 2.14
52-Week Low 1.84

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar